Riskpilot← Back to searchSign inGet full accessOPHTHALMA AB
ABActiveOrg 5564810249Idunagatan 57Medical specialists activities · NACE 8622Est. 19940 employees
Revenue 2024
SEK 964K
-9% vs 2023
EBITDA margin
73.7%
+74% vs 2023
Equity ratio
67.8%
Financial strength
Net profit 2024
SEK 444K
-14% vs 2023
| Revenue | SEK 964K | -9% |
| EBITDA | SEK 710K | +74% |
| Net profit | SEK 444K | -14% |
| Total assets | SEK 9,5M | +4% |
| Equity | SEK 6,5M | +4% |
| Employees | 0 | — |
Legal name
OPHTHALMA AB
Org number
5564810249
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
21 januari 1994
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva öppen hälso- och sjukvård, handel med och uthyrning av sjukvårdsartiklar, sjukvårdsutrustning och operationsverktyg, uthyrning av lokal och personal samt handel med värdepapper.
Address
Idunagatan 57
Phone
+46317010150
Email
drkg54@yahoo.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 771 | 2 572 | 1 198 | 1 056 | 964 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 657 | 1 791 | 505 | 407 | 710 |
| Depreciation & amort. | −12 | −187 | −187 | −187 | −152 |
| EBIT | 1 645 | 1 604 | 318 | 220 | 558 |
| Net financials | −1 | −1 | 18 | 239 | −161 |
| Profit before tax | 1 444 | 1 577 | 876 | 659 | 570 |
| Tax | −313 | −331 | −190 | −144 | −126 |
| Net profit | 1 131 | 1 246 | 686 | 515 | 444 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 7 513 | 8 758 | 8 946 | 9 114 | 9 520 |
| Equity | 4 335 | 5 394 | 5 894 | 6 222 | 6 451 |
| Long-term debt | 1 166 | 1 327 | 1 572 | 1 623 | 1 951 |
| Short-term debt | 212 | 210 | 193 | 181 | 203 |
| Total debt | 1 378 | 1 537 | 1 765 | 1 804 | 2 154 |
EBITDA margin
73.7%
This company
15.8%
Market median
+366% vs market
20202024
Equity ratio
67.8%
This company
38.2%
Market median
+77% vs market
20202024
Return on equity
6.9%
This company
18.4%
Market median
-63% vs market
20202024
Net profit margin
46.1%
This company
8.1%
Market median
+469% vs market
20202024
Asset turnover
0.10×
This company
1.12×
Market median
-91% vs market
20202024
Debt / equity
0.48×
This company
0.62×
Market median
+23% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
RL | Audit | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2021 | |
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of OPHTHALMA AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rolf Lennart Johansson | Audit | 0 companies |
| Nadja Kirilova Gramson | Deputy Board Member | 0 companies |
| Kristian Gramson | Board of Directors | 0 companies |